Navigation Links
New drug shows promise against multiple sclerosis
Date:11/1/2011

mune system attacks the myelin sheath that insulated nerve fibers in the brain and spinal cord. Most of these attacks have no associated symptoms, but damage to these sheaths can short circuit signals traveling along the nerve fibers. This disrupts the normal flow of communication from the brain and can cause a range of symptoms including visual impairment, weakness, sensory disturbance, fatigue, cognitive difficulties, and loss of coordination.

For decades, work in the field has focused on targeting one component of the immune system the T cells which were always seen as the "smoking gun" of the disease because they attack nerve fibers in the brain, causing the lesions and ultimately the symptoms of multiple sclerosis. Ocrelizumab, in contrast, targets a molecule called CD20 found on the surface of B cells, a separate component of the immune system.

Although the mechanism is not exactly clear, said Hauser, the B cells seem to induce the T cells to attack. If T cells are pulling the trigger on nerve fibers in the brain, B cells seem to be the ones that are loading the gun. The Phase 2 trial showed, in essence, that if you block one, you may be able to stop the other.

Hauser said the recently concluded trial validated the idea that targeting the B cells could ultimately help people with multiple sclerosis an idea that Hauser has championed for more than a decade after basic research in his laboratory in the 1990s suggested that these cells play a role in the disease.

"This is a great example of lessons learned at the bench bringing us to an experiment at the bedside that completely transformed our understanding of what we needed to do to develop more selective and more effective therapy for MS" he said.


'/>"/>
Contact: Jason Socrates Bardi
jason.bardi@ucsf.edu
415-502-4608
University of California - San Francisco
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Preterm birth rate shows three year improvement in most states
2. Study shows no increased risk of breast cancer for non-carriers in families with BRCA gene mutation
3. Novel approach to treat proliferative vitreoretinopathy shows promise
4. New therapy shows promise for treating cardiovascular disease
5. More Evidence Shows Newer Forms of Pill Raise Clot Risk, FDA Says
6. New oncolytic virus shows improved effectiveness in preclinical testing
7. Clinical trial shows first evidence that anal cancer is preventable
8. Through-the-nipple breast cancer therapy shows promise in early tests
9. Compound found in common wart treatment shows promise as leukemia therapy
10. Study shows why underrepresented men should be included in binge eating research
11. HIV Medication Patch Shows Promise in Early Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 22, 2015 The City of West Hollywood ... a.m., to commemorate the 42nd anniversary of the Supreme Court decision ... “It’s been 42 years since the Roe vs. Wade decision and ... as present as ever,” said City of West Hollywood Councilmember Abbe ...
(Date:1/22/2015)... TX (PRWEB) January 22, 2015 The Incredible ... Bodybuilder Ben Pakulski to increase lean muscle by up to ... has caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an ... that it is a step-by-step, scientific diet formula that allows ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David ... Show to bestow a Juvent Sports Achievement award upon ... McKitrick. The award commemorated and congratulated McKitrick for her ... won her first amateur tournament in 1979 and most ...
(Date:1/22/2015)... has released a new blog post presenting the basic features ... Purchasing an accidental death and dismemberment rider for a car ... provides benefits if the insured dies in an accident. Accidental ... life insurance. , AD&D is not expensive and can ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and easy ... treat specific body parts and muscle groups. , IsoComforter, ... use patented cold therapy machine with the innovative IsoTube design ... injuries. IsoComforter has become the industry leader in cold ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2
... China, May 13 /PRNewswire-Asia-FirstCall/ -- Jiangbo,Pharmaceuticals, Inc., (OTC ... changed its name from Genesis Pharmaceuticals Enterprises,Inc., OTC ... its,principal operations in the People,s Republic of China, ... call at 9:30 a.m. Eastern on Tuesday, May,19, ...
... Ill., May 13 The American Massage Therapy Association(R) ... ,erotic services, section as an opportunity to clarify for ... are not massage therapists. "The public and massage ... massage should only be the right of massage therapists," ...
... cyclists, fans and anyone interested in fitness will have plenty ... up to the 24th Los Angeles Marathon to be held ... up:>> Saturday, May 23: Run/Ex/09 , One of the largest ... South Hall of the Los Angeles Convention Center. More than ...
... near the University of Washington and Montlake Bridge ... Nordstrom Beat the Bridge to Beat Diabetes 8K run, which ... , From 7:30 a.m. until 10:00 a.m., Montlake Boulevard ... NE. 520 Ramp Closures , From 8:15 ...
... the newest "Biggest Loser" but she is a real champion ... about simple, everyday choices that can help you be healthy ... glass and is one of the simplest things you can ... athletes to don a ,stache for the National Milk Mustache ...
... 13 Speaker Nancy Pelosi received an "Award ... today on future directions in the fight against HIV/AIDS. ... select individuals in recognition of the vision, determination, and ... against AIDS. Other 2009 awardees are Senator Edward Kennedy, ...
Cached Medicine News:Health News:Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for its Third Quarter of FY 2009 2Health News:AMTA Applauds Craigslist Decision, Calls for Protection of Massage Therapists 2Health News:Full Calendar of Activities for 24th Los Angeles Marathon This Memorial Day Weekend 2Health News:Nordstrom Beat the Bridge to Beat Diabetes Run to Temporarily Suspend Traffic in University District on Sunday, May 17 2Health News:Pelosi Remarks at amfAR Conference on Future Directions in Fight Against HIV/AIDS 2
(Date:1/23/2015)... Feffer LLP ( www.hfesq.com ) is investigating potential claims ... or the "Company") (NASDAQ: ADXS ), concerning ... shareholders. On January 21, 2015, an article ... had misrepresented the clinical data for its ADXS-HPV drug ...
(Date:1/23/2015)... Companies, Inc. (ICBU) has repositioned itself as a holding company ... foothold in the hydroponic, hemp and medical marijuana sectors. By ... the sector, and recently partnering with the Chippewa Tribe Nation ... marijuana, iMD is committing to bring its vision to the ...
(Date:1/23/2015)... Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), ... extracorporeal cytokine adsorber to reduce deadly inflammation in ... of $385,642, net of transaction costs, in non-dilutive ... Business Tax Certificate Transfer Program sponsored by the ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
... FRANCISCO, Calif., May 1, 2012  Rigel Pharmaceuticals, Inc. (Nasdaq: ... ended March 31, 2012. For the first quarter ... or $0.32 per share, compared to a net loss of ... of 2011. Weighted average shares outstanding for the first quarters ...
... (NYSE: SHP ) ("ShangPharma" or the ... and development outsourcing company, today announced that it ... for the year ended December 31, 2011 with ... "SEC"). The annual report can be accessed on ...
Cached Medicine Technology:Rigel Announces First Quarter 2012 Financial Results 2Rigel Announces First Quarter 2012 Financial Results 3Rigel Announces First Quarter 2012 Financial Results 4ShangPharma Corporation Files 2011 Annual Report on Form 20-F 2
Latex-free coronary artery perfusion/cardioplegia infusion cannulae....
... the clarity of daylight into the surgical ... Source. Designed for a variety of applications ... and video equipment - this light source ... watts (6,000o K) for superb tissue definition, ...
... the Novametrix' family of capnography products. Along ... are the only handheld, mainstream capnographs available ... patient's airway condition and ventilatory status. Based ... capnographs, we miniaturized the size, not the ...
Designed for simple operation, the Model 515B pulse oximeter is ideal for use in any clinical setting; from emergency hospital transport to continuous monitoring in Anesthesia, Intensive Care and Gen...
Medicine Products: